Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Got some mail
View:
Post by Oilminerdeluxe on Aug 16, 2024 6:33am

Got some mail

Got this in the mail. How on God's grean earth can we have such problem finding money? I will never understand. Probably for the best
Key highlights from the Press Release:

  • 72 Patients treated
  • 63% Complete Response
  • 48% Duration of Complete Response at 1 year
  • 44% Duration of Complete Response at 15 months
  • 90% of patients who achieve Complete Response at 450 days continue this response beyond 450 days

We are very encouraged by these best-in-class duration results demonstrating a duration or reponse of over 3 years for many patients. 

Comment by Lesalpes29 on Aug 16, 2024 6:47am
Got it yesterday too. I can,'t fund them, I am just a tiny investor. Is it the best way to get money? Really not sure. The ball is in manage hands. GL
Comment by riverrrow on Aug 16, 2024 10:00am
They must have two different email lists.  Some emails I get, some I don't.
Theralase Technologies Inc.